Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 15;117(8):1711-20.
doi: 10.1002/cncr.25643. Epub 2010 Nov 8.

Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival

Jan Zakrzewski  1 , Laurel N Geraghty, Amy E Rose, Paul J Christos, Madhu Mazumdar, David Polsky, Richard Shapiro, Russell Berman, Farbod Darvishian, Eva Hernando, Anna Pavlick, Iman Osman
Affiliations

Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival

Jan Zakrzewski et al. Cancer. .

Abstract

Background: Melanoma patients who develop brain metastases (B-Met) have limited survival and are excluded from most clinical trials. In the current study, the authors attempted to identify primary tumor characteristics and clinical features predictive of B-Met development and post-B-Met survival.

Methods: A prospectively accrued cohort of 900 melanoma patients was studied to identify clinicopathologic features of primary melanoma (eg, thickness, ulceration, mitotic index, and lymphovascular invasion) that are predictive of B-Met development and survival after a diagnosis of B-Met. Associations between clinical variables present at the time of B-Met diagnosis (eg, extracranial metastases, B-Met location, and the presence of neurological symptoms) and post-B-Met survival were also assessed. Univariate associations were analyzed using Kaplan-Meier survival analysis, and the effect of independent predictors was assessed using multivariate Cox proportional hazards regression analysis.

Results: Of the 900 melanoma patients studied, 89 (10%) developed B-Met. Ulceration and site of the primary tumor on the head and neck were found to be independent predictors of B-Met development on multivariate analysis (P = .001 and P = .003, respectively). Clinical variables found to be predictive of post-B-Met survival on multivariate analysis included the presence of neurological symptoms (P = .008) and extracranial metastases (P = .04). Ulceration was the only primary tumor characteristic that remained a significant predictor of post-B-Met survival on multivariate analysis (P = .04).

Conclusions: Primary tumor ulceration was found to be the strongest predictor of B-Met development and remained an independent predictor of decreased post-B-Met survival in a multivariate analysis inclusive of primary tumor characteristics and clinical variables. The results of the current study suggest that patients with ulcerated primary tumors should be prospectively studied to determine whether heightened surveillance for B-Met can improve clinical outcome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Melanoma patients who developed brain metastases (B-Met) stratified by AJCC clinical stage at time of initial melanoma diagnosis.
Figure 2
Figure 2
Kaplan-Meier estimates of post-B-Met survival for patients with or without primary tumor ulceration (A), with or without primary tumor LVI (B), and with none/few vs. moderate/many mitotic figures (C).
See this image and copyright information in PMC

Comment in

References

    1. Sampson JH, Carter JH, Jr, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88(1):11–20. - PubMed
    1. Fife KM, Colman MH, Stevens GN, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004;22(7):1293–1300. - PubMed
    1. Meier S, Baumert BG, Maier T, et al. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie. 2004;27(2):145–149. - PubMed
    1. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37(4):745–751. - PubMed
    1. Thompson JF, Morton D, Kroon B. Textbook of Melanoma. vol. 1. London: Martin Dunitz; 2004.

Publication types